NUWELLIS INC (NUWE)
US67113Y4052 - Common Stock
NUWELLIS INC
NASDAQ:NUWE (5/2/2024, 10:14:02 AM)
0.1575
+0.03 (+21.15%)
Company Profile
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 70 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex SmartFlow and the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filter, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Company Info
NUWELLIS INC
12988 Valley View Rd
Eden Prairie MINNESOTA 55344
P: 19523454200
CEO: Nestor Jaramillo
Employees: 70
Website: https://www.nuwellis.com/
NUWE News
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the closing of its previously announced public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price of $0.24 per share (or pre-funded warrant in lieu thereof) and associated warrant. Each share of common stock (or prefunded warrant in lieu thereof) was sold together with one warrant to purchase one and a half shares of common stock. The warrants have an exercise price of $0.40 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people...
3 days ago - ChartmillUnusual volume stocks in Monday's sessionUnusual volume stocks in Monday's session
6 days ago - ChartmillTop movers in Friday's sessionLet's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
6 days ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
6 days ago - ChartmillWhat's going on in today's sessionLet's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
NUWE Twits
Here you can normally see the latest stock twits on NUWE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
